TOFA suppresses ovarian cancer cell growth in vitro and in vivo

Li,Shu; Qiu,Lihua; Wu,Buchu; Shen,Haoran; Zhu,Jing; Zhou,Liang; Gu,Liying; Di,Wen

doi:10.3892/mmr.2013.1505

TOFA suppresses ovarian cancer cell growth in vitro and in vivo

Authors:
- Shu Li
- Lihua Qiu
- Buchu Wu
- Haoran Shen
- Jing Zhu
- Liang Zhou
- Liying Gu
- Wen Di
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, P.R. China
Published online on: May 31, 2013 https://doi.org/10.3892/mmr.2013.1505
Pages: 373-378

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

A characteristic feature of cancer cells is the activation of de novo fatty acid synthesis. Acetyl‑CoA carboxylase (ACC) is a key enzyme in fatty acid synthesis, accelerating the reaction that carboxylates cytosolic acetyl‑CoA to form malonyl‑CoA. ACC is highly expressed in several types of human cancer and is important in breast and prostate cancer cell growth. The aim of the present study was to investigate the effects of 5‑tetradecyloxy‑2‑furoic acid (TOFA), an allosteric inhibitor of ACC, on the proliferation and cell cycle progression of the ovarian cancer cell lines COC1 and COC1/DDP. TOFA was found to be cytotoxic to COC1 and COC1/DDP cells with a 50% inhibitory concentration (IC50) of ~26.1 and 11.6 µg/ml, respectively. TOFA inhibited the proliferation of the cancer cells examined in a time‑ and dose‑dependent manner, arrested the cells in the G0/G1 cell cycle phase and induced apoptosis. The expression of the cell cycle regulating proteins cyclin D1 and cyclin-dependent kinase (CDK) 4, as well as the expression of the apoptosis‑related proteins caspase‑3 and Bcl‑2, were detected by western blot analysis. Cyclin D1, CDK4 and Bcl‑2 protein expression was inhibited by TOFA, while caspase‑3 was cleaved and activated. To the best of our knowledge, the present study demonstrated for the first time that TOFA inhibits COC1/DDP cell growth in ovarian tumor mouse xenografts. By inhibiting ACC, TOFA may be a promising small molecule agent for ovarian cancer therapy.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
2	Eltabbakh GH and Awtrey CS: Current treatment for ovarian cancer. Expert Opin Pharmacother. 2:109–124. 2001. View Article : Google Scholar
3	Herzog TJ: The current treatment of recurrent ovarian cancer. Curr Oncol Rep. 8:448–454. 2006. View Article : Google Scholar : PubMed/NCBI
4	Wakil SJ, Stoops JK and Joshi VC: Fatty acid synthesis and its regulation. Annu Rev Biochem. 52:537–579. 1983. View Article : Google Scholar : PubMed/NCBI
5	Barber MC, Price NT and Travers MT: Structure and regulation of acetyl-CoA carboxylase genes of metazoa. Biochim Biophys Acta. 1733:1–28. 2005. View Article : Google Scholar : PubMed/NCBI
6	Griffin MJ and Sul HS: Insulin regulation of fatty acid synthase gene transcription: roles of USF and SREBP-1c. IUBMB Life. 56:595–600. 2004. View Article : Google Scholar : PubMed/NCBI
7	Hardie DG and Pan DA: Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem Soc Trans. 30(Pt 6): 1064–1070. 2002. View Article : Google Scholar : PubMed/NCBI
8	Abu-Elheiga L, Brinkley WR, Zhong L, Chirala SS, Woldegiorgis G and Wakil SJ: The subcellular localization of acetyl-CoA carboxylase. Proc Natl Acad Sci USA. 97:1444–1449. 2000. View Article : Google Scholar : PubMed/NCBI
9	Chen ZP, McConell GK, Michell BJ, Snow RJ, Canny BJ and Kemp BE: AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab. 279:E1202–E1206. 2000.PubMed/NCBI
10	Milgraum LZ, Witters LA, Pasternack GR and Kuhajda FP: Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clin Cancer Res. 3:2115–2120. 1997.PubMed/NCBI
11	Witters LA, Widmer J, King AN, Fassihi K and Kuhajda F: Identification of human acetyl-CoA carboxylase isozymes in tissue and in breast cancer cells. Int J Biochem. 26:589–594. 1994. View Article : Google Scholar : PubMed/NCBI
12	Yahagi N, Shimano H, Hasegawa K, Ohashi K, Matsuzaka T, Najima Y, Sekiya M, Tomita S, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, Nagai R, Ishibashi S, Kadowaki T, Makuuchi M, Ohnishi S, Osuga J and Yamada N: Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma. Eur J Cancer. 41:1316–1322. 2005. View Article : Google Scholar : PubMed/NCBI
13	Chajès V, Cambot M, Moreau K, Lenoir GM and Joulin V: Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival. Cancer Res. 66:5287–5294. 2006.PubMed/NCBI
14	Brusselmans K, De Schrijver E, Verhoeven G and Swinnen JV: RNA interference-mediated silencing of the acetyl-CoA-carboxylase-alpha gene induces growth inhibition and apoptosis of prostate cancer cells. Cancer Res. 65:6719–6725. 2005. View Article : Google Scholar : PubMed/NCBI
15	Wang C, Xu C, Sun M, Luo D, Liao DF and Cao D: Acetyl-CoA carboxylase-alpha inhibitor TOFA induces human cancer cell apoptosis. Biochem Biophys Res Commun. 385:302–306. 2009. View Article : Google Scholar : PubMed/NCBI
16	McCune SA and Harris RA: Mechanism responsible for 5-(tetradecyloxy)-2-furoic acid inhibition of hepatic lipogenesis. J Biol Chem. 254:10095–10101. 1979.PubMed/NCBI
17	Tong L and Harwood HJ Jr: Acetyl-coenzyme A carboxylases: versatile targets for drug discovery. J Cell Biochem. 99:1476–1488. 2006. View Article : Google Scholar : PubMed/NCBI
18	Harwood HJ Jr: Treating the metabolic syndrome: acetyl-CoA carboxylase inhibition. Expert Opin Ther Targets. 9:267–281. 2005. View Article : Google Scholar : PubMed/NCBI
19	Halvorson DL and McCune SA: Inhibition of fatty acid synthesis in isolated adipocytes by 5-(tetradecyloxy)-2-furoic acid. Lipids. 19:851–856. 1984. View Article : Google Scholar : PubMed/NCBI
20	Guseva NV, Rokhlin OW, Glover RA and Cohen MB: TOFA (5-tetradecyl-oxy-2-furoic acid) reduces fatty acid synthesis, inhibits expression of AR, neuropilin-1 and Mcl-1 and kills prostate cancer cells independent of p53 status. Cancer Biol Ther. 12:80–85. 2011. View Article : Google Scholar : PubMed/NCBI
21	Oda T, Hayano T, Miyaso H, Takahashi N and Yamashita T: Hsp90 regulates the Fanconi anemia DNA damage response pathway. Blood. 109:5016–5026. 2007. View Article : Google Scholar : PubMed/NCBI
22	Zhong Q, Wen YJ, Yang HS, Luo H, Fu AF, Yang F, Chen LJ, Chen X, Qi XR, Lin HG, Wan Y, Chen XC, Wei YQ and Zhao X: Efficient inhibition of cisplatin-resistant human ovarian cancer growth and prolonged survival by gene transferred vesicular stomatitis virus matrix protein in nude mice. Ann Oncol. 19:1584–1591. 2008. View Article : Google Scholar
23	Kuhajda FP: Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition. 16:202–208. 2000. View Article : Google Scholar : PubMed/NCBI
24	Zhou W, Han WF, Landree LE, Thupari JN, Pinn ML, Bililign T, Kim EK, Vadlamudi A, Medghalchi SM, El Meskini R, Ronnett GV, Townsend CA and Kuhajda FP: Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells. Cancer Res. 67:2964–2971. 2007. View Article : Google Scholar : PubMed/NCBI
25	D’Andrilli G, Kumar C, Scambia G and Giordano A: Cell cycle genes in ovarian cancer: steps toward earlier diagnosis and novel therapies. Clin Cancer Res. 10:8132–8141. 2004.PubMed/NCBI
26	Aggarwal P, Vaites LP, Kim JK, Mellert H, Gurung B, Nakagawa H, Herlyn M, Hua X, Rustgi AK, McMahon SB and Diehl JA: Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase. Cancer Cell. 18:329–340. 2010. View Article : Google Scholar : PubMed/NCBI
27	Ray H, Suau F, Vincent A and Dalla Venezia N: Cell cycle regulation of the BRCA1/acetyl-CoA-carboxylase complex. Biochem Biophys Res Commun. 378:615–619. 2009. View Article : Google Scholar : PubMed/NCBI